← Back to Company DatabaseVisit Website
Triomics
Generative AI platform for oncology EHRs and clinical trial matching.
Series BSan Francisco, CAFounded 2020
About
Triomics uses its OncoLLM oncology-focused language models to help cancer care providers reduce the burden of manually reviewing patient charts, accelerate clinical trial enrollment, and power quality improvement projects. Its Prism product pre-screens patients against trial criteria in real-time, identifying 90% of eligible patients in minutes.
Total Funding
$29MKey Product
Triomics Prism clinical trial matching platformGeography
North AmericaKey Investors
LightspeedGeneral CatalystY Combinator
Focus Areas
AI / Machine LearningData / AnalyticsPatient Navigation / Support
Technology
AI / Machine LearningDigital Health / Software
Cancer Types
Pan-cancer
Last updated: Feb 4, 2026